ATHX Share Price | Athersys, Inc. Stock Analysis & Recommendation

Q: How big is Athersys, Inc.?

Market Cap: As of Jun 18, Athersys, Inc. has a market capitalization of 0.00, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, Athersys, Inc. reported net sales of 0.08 million and a net profit of -37.50 million.Balance Sheet Snapshot: As of Dec 22, the company reported shareholder's funds of -23.85 million and total assets of 27.73 million.

Q: Who are in the management team of Athersys, Inc.?

As of March 2022, the management team of Athersys, Inc. includes the following individuals:- Dr. Gil Van Bokkelen, who serves as the Chairman of the Board and Chief Executive Officer.- Dr. John Harrington, who is the Executive Vice President, Chief Scientific Officer, and a Director.- Dr. Hardy Kagimoto, who is a Director.- Ms. Katherine Kalin, who is also a Director.- Mr. Baiju Shah, who serves as a Director.- Ms. Jane Wasman, who is a Director.- Dr. Ismail Kola, who is an Independent Director. This team is responsible for guiding the company's strategic direction and operations.

Q: Is Athersys, Inc. overvalued or undervalued?

As of 16 August 2023, Athersys, Inc. has moved from a grade of risky to does not qualify, indicating significant concerns regarding its valuation. The company is currently assessed as overvalued given its financial ratios, including a P/E ratio of 0.00 and an EV to EBITDA of -0.43, which suggest a lack of profitability and negative enterprise value metrics. Furthermore, the ROE stands at an extraordinarily high 118.05%, but this is misleading due to negative capital employed, highlighting the company's precarious financial situation.In comparison to its peers, such as Frequency Therapeutics, Inc. with a P/E of -1.3504 and Landos Biopharma, Inc. with a P/E of -2.9258, Athersys does not present a compelling investment case. The overall peer group reflects a challenging environment, with many companies also classified as not qualifying or risky. Given these factors, Athersys appears to be overvalued, especially considering its drastic stock performance, which has seen a 100% decline over the past year compared to a 10.26% return for the S&P 500.

Q: Is Athersys, Inc. technically bullish or bearish?

As of 16 October 2023, the technical trend for Athersys, Inc. has changed from bearish to mildly bearish. The weekly MACD and KST indicators are mildly bullish, while the monthly MACD is also mildly bullish and the RSI is bullish. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands are showing a sideways trend for both weekly and monthly periods, and there is no discernible trend according to Dow Theory and OBV. There is no available return data to compare the company's performance against the S&P 500. Overall, the current technical stance is mildly bearish, with mixed signals across different time frames.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Dec 2023)

FII

0.48%

Held by 28 FIIs

DII

96.95%

Held by 3 DIIs

Promoter

0.00%

How big is Athersys, Inc.?

22-Jun-2025

As of Jun 18, Athersys, Inc. has a market capitalization of 0.00, classifying it as a Micro Cap company, with recent net sales of 0.08 million and a net profit of -37.50 million. The company reported shareholder's funds of -23.85 million and total assets of 27.73 million as of Dec 22.

View full answer

Who are in the management team of Athersys, Inc.?

22-Jun-2025

As of March 2022, Athersys, Inc.'s management team includes Dr. Gil Van Bokkelen (Chairman and CEO), Dr. John Harrington (Executive VP and Chief Scientific Officer), and several directors: Dr. Hardy Kagimoto, Ms. Katherine Kalin, Mr. Baiju Shah, Ms. Jane Wasman, and Dr. Ismail Kola (Independent Director). They oversee the company's strategic direction and operations.

View full answer

Is Athersys, Inc. overvalued or undervalued?

25-Jun-2025

As of August 16, 2023, Athersys, Inc. is considered overvalued and in a precarious financial situation, with a P/E ratio of 0.00 and negative enterprise value metrics, reflecting a 100% stock decline over the past year compared to a 10.26% return for the S&P 500.

View full answer

Is Athersys, Inc. technically bullish or bearish?

20-Sep-2025

As of October 16, 2023, Athersys, Inc. shows a mildly bearish trend with mixed technical signals, including mildly bullish weekly and monthly MACD and RSI indicators, but daily moving averages indicate a bearish stance.

View full answer

Compare Athersys, Inc. with Similar Stocks

Aravive, Inc.Imunon, Inc.Organovo Holdings, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.48

Return on Equity

118.05%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2023)

Net Profit:

-4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

0.0%

1 Year

-100.0%

2 Years

-100.0%

3 Years

-100.0%

4 Years

-100.0%

5 Years

-100.0%

Athersys, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-68.03%

EBIT Growth (5y)

-31.57%

EBIT to Interest (avg)

-55.74

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.48

Sales to Capital Employed (avg)

0.52

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.84%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-0.42

EV to EBITDA

-0.43

EV to Capital Employed

-0.93

EV to Sales

17.56

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

118.05%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 19 Schemes (2.58%)

Foreign Institutions

Held by 28 Foreign Institutions (0.48%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Jun 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2023 is 70.54% vs -65.38% in Jun 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.50",
          "val2": "-12.90",
          "chgp": "49.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "2.00",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.80",
          "val2": "-12.90",
          "chgp": "70.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-265,061.20%",
          "chgp": "26,506.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is -3.64% vs 292.86% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 16.67% vs -10.41% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.30",
          "val2": "5.50",
          "chgp": "-3.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-75.60",
          "val2": "-85.40",
          "chgp": "11.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.70",
          "val2": "-0.50",
          "chgp": "840.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-72.50",
          "val2": "-87.00",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14,367.90%",
          "val2": "-15,697.90%",
          "chgp": "133.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'23 - QoQ

Sep'23

Jun'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-6.50

-12.90

49.61%

Interest

0.20

0.40

-50.00%

Exceptional Items

3.50

2.00

75.00%

Consolidate Net Profit

-3.80

-12.90

70.54%

Operating Profit Margin (Excl OI)

0.00%

-265,061.20%

26,506.12%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Jun 2023

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2023 is 70.54% vs -65.38% in Jun 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

5.30

5.50

-3.64%

Operating Profit (PBDIT) excl Other Income

-75.60

-85.40

11.48%

Interest

0.00

Exceptional Items

3.70

-0.50

840.00%

Consolidate Net Profit

-72.50

-87.00

16.67%

Operating Profit Margin (Excl OI)

-14,367.90%

-15,697.90%

133.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is -3.64% vs 292.86% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 16.67% vs -10.41% in Dec 2021

All Annual Results

Company CV

About Athersys, Inc.

Athersys, Inc.

Pharmaceuticals & Biotechnology

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.

Company Coordinates

Company Details

3201 Carnegie Ave , CLEVELAND OH : 44115-2634

Tel: 1 216 4319900

http://www.athersys.com/

Registrar Details

Athersys, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Athersys, Inc.?

Watch in Real-Time

Who are in the management team of Athersys, Inc.?

Is Athersys, Inc. overvalued or undervalued?

Is Athersys, Inc. technically bullish or bearish?

Compare Athersys, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'23 - QoQ

Annual Results Snapshot (Consolidated) - Dec'22

About Athersys, Inc.

Company Coordinates